These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3527559)

  • 21. Acquired immune deficiency syndrome (AIDS) HTLV III/LAV; the causal agent and modes of transmission.
    Smithies A
    Health Bull (Edinb); 1986 Jul; 44(4):234-8. PubMed ID: 3017891
    [No Abstract]   [Full Text] [Related]  

  • 22. The AIDS epidemic: six years.
    Osborn JE
    Annu Rev Public Health; 1988; 9():551-83. PubMed ID: 3288243
    [No Abstract]   [Full Text] [Related]  

  • 23. Assessment of screening as a preventive technology: the example of HTLV-III/LAV antibody testing.
    Ory HW; Koplan JP; Allen JR
    Isr J Med Sci; 1986; 22(7-8):524-8. PubMed ID: 3640749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of nosocomial infection with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workers.
    Henderson DK; Saah AJ; Zak BJ; Kaslow RA; Lane HC; Folks T; Blackwelder WC; Schmitt J; LaCamera DJ; Masur H
    Ann Intern Med; 1986 May; 104(5):644-7. PubMed ID: 3963663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquired immunodeficiency syndrome: meeting of the WHO Collaborating Centres on AIDS.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Nov; 34(44):678-9. PubMed ID: 3932833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of different sexual-contact patterns between age classes on the predicted demographic impact of AIDS in developing countries.
    Anderson RM; Ng TW; Boily MC; May RM
    Ann N Y Acad Sci; 1989; 569():240-74. PubMed ID: 2698092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update: acquired immunodeficiency syndrome--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Jan; 35(2):17-21. PubMed ID: 3079867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired immune deficiency syndrome (AIDS): disease manifestations and dental management.
    Molinari JA; Merchant VA; Barrett ED
    J Mich Dent Assoc; 1984 Mar; 66(3):113-20. PubMed ID: 6233424
    [No Abstract]   [Full Text] [Related]  

  • 29. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia.
    Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL
    JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R; Redfield RR; Broder S
    J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [LAV/HTLV III infection in homosexual and bisexual men--data on transmission and risk markers in Stockholm].
    Karlsson A; Bratt G; Moberg L; von Krogh G; Hedqvist B; Morfeldt JO; Böttiger B; Biberfeld G; Böttiger M; Hellström L
    Lakartidningen; 1986 Aug; 83(35):2834-7. PubMed ID: 3462445
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunopathogenesis of the acquired immunodeficiency syndrome.
    Bowen DL; Lane HC; Fauci AS
    Ann Intern Med; 1985 Nov; 103(5):704-9. PubMed ID: 2996403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberculosis--United States, 1985--and the possible impact of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Feb; 35(5):74-6. PubMed ID: 3080659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding AIDS.
    Davis MC
    Caring; 1993 May; 12(5):5, 7-13. PubMed ID: 10125249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AIDS: the search for clues.
    WHO Chron; 1985; 39(6):207-11. PubMed ID: 3012884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transmission of acquired immune deficiency syndrome (AIDS) by a blood transfusion given in 1979 in Israel.
    Kleinman Y; Yust I; Maayan S; Rave D; Merdler C; Michaeli D; Schlesinger M
    Isr J Med Sci; 1986 May; 22(5):404-7. PubMed ID: 3017890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent developments in the diagnosis and treatment of AIDS and related syndromes.
    Dickinson G
    Med Sect Proc; 1993; ():41-52. PubMed ID: 8078872
    [No Abstract]   [Full Text] [Related]  

  • 39. High prevalence and high titers of LAV/HTLV-III antibodies in healthy hemophiliacs in the midwestern United States.
    Goldsmith JC; Dewhurst S; Hedenskog M; Casareale D; Volsky DJ
    Am J Med; 1986 Oct; 81(4):579-83. PubMed ID: 3532787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychosocial and behavioral factors associated with risk of sexually transmitted diseases, including human immunodeficiency virus infection, among urban high school students.
    Shafer MA; Boyer CB
    J Pediatr; 1991 Nov; 119(5):826-33. PubMed ID: 1941394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.